Index
1 Market Overview of Narcolepsy Treatment
1.1 Narcolepsy Treatment Market Overview
1.1.1 Narcolepsy Treatment Product Scope
1.1.2 Narcolepsy Treatment Market Status and Outlook
1.2 Global Narcolepsy Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Narcolepsy Treatment Market Size by Region (2018-2029)
1.4 Global Narcolepsy Treatment Historic Market Size by Region (2018-2023)
1.5 Global Narcolepsy Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Narcolepsy Treatment Market Size (2018-2029)
1.6.1 North America Narcolepsy Treatment Market Size (2018-2029)
1.6.2 Europe Narcolepsy Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Narcolepsy Treatment Market Size (2018-2029)
1.6.4 Latin America Narcolepsy Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Narcolepsy Treatment Market Size (2018-2029)
2 Narcolepsy Treatment Market by Type
2.1 Introduction
2.1.1 Sodium Oxybate
2.1.2 Antidepressants
2.1.3 Central Nervous System Stimulants
2.1.4 Others
2.2 Global Narcolepsy Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Narcolepsy Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Narcolepsy Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Narcolepsy Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Narcolepsy Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Narcolepsy Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Narcolepsy Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Narcolepsy Treatment Revenue Breakdown by Type (2018-2029)
3 Narcolepsy Treatment Market Overview by Application
3.1 Introduction
3.1.1 Primary Narcolepsy with Cataplexy
3.1.2 Primary Narcolepsy without Cataplexy
3.1.3 Narcolepsy Due to Medical Conditions
3.1.4 Unspecified Narcolepsy
3.2 Global Narcolepsy Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Narcolepsy Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Narcolepsy Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Narcolepsy Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Narcolepsy Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Narcolepsy Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Narcolepsy Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Narcolepsy Treatment Revenue Breakdown by Application (2018-2029)
4 Narcolepsy Treatment Competition Analysis by Players
4.1 Global Narcolepsy Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Narcolepsy Treatment as of 2022)
4.3 Date of Key Players Enter into Narcolepsy Treatment Market
4.4 Global Top Players Narcolepsy Treatment Headquarters and Area Served
4.5 Key Players Narcolepsy Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Narcolepsy Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Teva Pharmaceutical
5.1.1 Teva Pharmaceutical Profile
5.1.2 Teva Pharmaceutical Main Business
5.1.3 Teva Pharmaceutical Narcolepsy Treatment Products, Services and Solutions
5.1.4 Teva Pharmaceutical Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Teva Pharmaceutical Recent Developments
5.2 Takeda
5.2.1 Takeda Profile
5.2.2 Takeda Main Business
5.2.3 Takeda Narcolepsy Treatment Products, Services and Solutions
5.2.4 Takeda Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Takeda Recent Developments
5.3 Jazz Pharmaceuticals
5.3.1 Jazz Pharmaceuticals Profile
5.3.2 Jazz Pharmaceuticals Main Business
5.3.3 Jazz Pharmaceuticals Narcolepsy Treatment Products, Services and Solutions
5.3.4 Jazz Pharmaceuticals Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Arena Pharmaceuticals Recent Developments
5.4 Arena Pharmaceuticals
5.4.1 Arena Pharmaceuticals Profile
5.4.2 Arena Pharmaceuticals Main Business
5.4.3 Arena Pharmaceuticals Narcolepsy Treatment Products, Services and Solutions
5.4.4 Arena Pharmaceuticals Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Arena Pharmaceuticals Recent Developments
5.5 Graymark Healthcare
5.5.1 Graymark Healthcare Profile
5.5.2 Graymark Healthcare Main Business
5.5.3 Graymark Healthcare Narcolepsy Treatment Products, Services and Solutions
5.5.4 Graymark Healthcare Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Graymark Healthcare Recent Developments
5.6 Ligand Pharmaceuticals
5.6.1 Ligand Pharmaceuticals Profile
5.6.2 Ligand Pharmaceuticals Main Business
5.6.3 Ligand Pharmaceuticals Narcolepsy Treatment Products, Services and Solutions
5.6.4 Ligand Pharmaceuticals Narcolepsy Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Ligand Pharmaceuticals Recent Developments
6 North America
6.1 North America Narcolepsy Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Narcolepsy Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Narcolepsy Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Narcolepsy Treatment Market Dynamics
11.1 Narcolepsy Treatment Industry Trends
11.2 Narcolepsy Treatment Market Drivers
11.3 Narcolepsy Treatment Market Challenges
11.4 Narcolepsy Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List